These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21330323)

  • 1. Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response.
    Colado E; Paíno T; Maiso P; Ocio EM; Chen X; Alvarez-Fernández S; Gutiérrez NC; Martín-Sánchez J; Flores-Montero J; San Segundo L; Garayoa M; Fernández-Lázaro D; Vidriales MB; Galmarini CM; Avilés P; Cuevas C; Pandiella A; San-Miguel JF
    Haematologica; 2011 May; 96(5):687-95. PubMed ID: 21330323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks.
    Ocio EM; Maiso P; Chen X; Garayoa M; Alvarez-Fernández S; San-Segundo L; Vilanova D; López-Corral L; Montero JC; Hernández-Iglesias T; de Alava E; Galmarini C; Avilés P; Cuevas C; San-Miguel JF; Pandiella A
    Blood; 2009 Apr; 113(16):3781-91. PubMed ID: 19020308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells.
    Zhao J; Xie C; Edwards H; Wang G; Taub JW; Ge Y
    Oncotarget; 2017 Jan; 8(4):6319-6329. PubMed ID: 28030834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
    Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
    Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51.
    Xie C; Drenberg C; Edwards H; Caldwell JT; Chen W; Inaba H; Xu X; Buck SA; Taub JW; Baker SD; Ge Y
    PLoS One; 2013; 8(11):e79106. PubMed ID: 24244429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
    Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
    Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo.
    Liu F; Knight T; Su Y; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Sun L; Ge Y
    Target Oncol; 2019 Jun; 14(3):351-364. PubMed ID: 31115744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
    Cramer-Morales K; Nieborowska-Skorska M; Scheibner K; Padget M; Irvine DA; Sliwinski T; Haas K; Lee J; Geng H; Roy D; Slupianek A; Rassool FV; Wasik MA; Childers W; Copland M; Müschen M; Civin CI; Skorski T
    Blood; 2013 Aug; 122(7):1293-304. PubMed ID: 23836560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104).
    Romano M; Frapolli R; Zangarini M; Bello E; Porcu L; Galmarini CM; García-Fernández LF; Cuevas C; Allavena P; Erba E; D'Incalci M
    Int J Cancer; 2013 Nov; 133(9):2024-33. PubMed ID: 23588839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.
    Konopleva M; Tsao T; Ruvolo P; Stiouf I; Estrov Z; Leysath CE; Zhao S; Harris D; Chang S; Jackson CE; Munsell M; Suh N; Gribble G; Honda T; May WS; Sporn MB; Andreeff M
    Blood; 2002 Jan; 99(1):326-35. PubMed ID: 11756188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
    Prus E; Fibach E
    Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine.
    Walsby EJ; Coles SJ; Knapper S; Burnett AK
    Haematologica; 2011 Mar; 96(3):393-9. PubMed ID: 21134979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in rpS6 phosphorylation and BH3 profiling predict response to chemotherapy in AML cells.
    Grundy M; Jones T; Elmi L; Hall M; Graham A; Russell N; Pallis M
    PLoS One; 2018; 13(5):e0196805. PubMed ID: 29723246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia.
    Xie C; Edwards H; Xu X; Zhou H; Buck SA; Stout ML; Yu Q; Rubnitz JE; Matherly LH; Taub JW; Ge Y
    Clin Cancer Res; 2010 Nov; 16(22):5499-510. PubMed ID: 20889917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair.
    Maiso P; Colado E; Ocio EM; Garayoa M; Martín J; Atadja P; Pandiella A; San-Miguel JF
    Leukemia; 2009 Dec; 23(12):2265-74. PubMed ID: 19812608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia.
    Haines E; Nishida Y; Carr MI; Montoya RH; Ostermann LB; Zhang W; Zenke FT; Blaukat A; Andreeff M; Vassilev LT
    Sci Rep; 2021 Jun; 11(1):12148. PubMed ID: 34108527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
    Kim HP; Gerhard B; Harasym TO; Mayer LD; Hogge DE
    Exp Hematol; 2011 Jul; 39(7):741-50. PubMed ID: 21530609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boric Acid Affects the Expression of DNA Double-Strand Break Repair Factors in A549 Cells and A549 Cancer Stem Cells: An In Vitro Study.
    Semerci Sevimli T; Ghorbani A; Demir Cevizlidere B; Altuğ B; Sevimli M
    Biol Trace Elem Res; 2024 Nov; 202(11):5017-5024. PubMed ID: 38367174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
    Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC
    Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro.
    Chen WA; Williams TG; So L; Drew N; Fang J; Ochoa P; Nguyen N; Jawhar Y; Otiji J; Duerksen-Hughes PJ; Reeves ME; Casiano CA; Jin H; Dovat S; Yang J; Boyle KE; Francis-Boyle OL
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.